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There is no doubt that secondary growth of blood vessels, so-
called angiogenesis (Jakob et al, 1977), plays an important role in
a variety of different pathological conditions (Folkman, 1995). In
particular, angiogenesis has been described to be essential for the
growth and persistence of solid tumours and their metastases
(Folkman et al, 1989; Millauer et al, 1994) and is known to be
modulated by a variety of different molecules (Yancopoulos et al,
1998). 
A widely accepted concept describes a pre-vascular growth
phase of solid tumours which is followed by an angiogenic switch
to a vascular phase initiated through the release of angiogenesis
factors (Folkman et al, 1989; Carmeliet, 2000). However, there is
also evidence that neoangiogenesis sets in before the shift towards
invasive phenotypes (Smith-McCune and Weidner, 1994). 
In addition, tumour vessel density is in a variety of tumours 
a predictive parameter for metastatic propagation and/or overall
survival or relapse-free survival, e.g., in breast (Weidner et al, 1991,
1992) and prostate cancer (Weidner et al, 1993), in melanomas
(Herlyn et al, 1987), colorectal carcinomas (Ishikawa et al, 1999) and
oesophageal carcinomas (Kitadai et al, 1998). 
We have recently shown that xenografts from different murine
and human tumour cell lines display significant differences in their
microvascular architecture in terms of tumour type-specific inter-
vascular distances, interbranching distances, as well as vascular
diameters (Konerding et al, 1999). This inherent tumour architec-
ture is widely retained even under the influence of highly angio-
genic and/or tumourigenic factors such as FGF-II (Konerding et al,
1998). 
However, no quantitative data exist on the 3D microvascular
architecture in human primary tumours and their precursor lesions.
This prompted us to examine the 3D vascular network of normal
colon mucosa, adenomas and invasive carcinomas by means of
microvascular corrosion casting. Comparisons with the expression
of VEGF as an angiogenic factor of utmost importance should
elucidate the time course of new vessel formation in the progres-
sion from adenomas to invasive carcinomas. 
MATERIALS AND METHODS 
Patients and specimens 
Fresh hemicolectomy specimens were obtained from 19 patients
undergoing surgery for colorectal cancer and 1 patient with poly-
posis coli plus a carcinoma for microvascular corrosion casting
and factor VIII and VEGF staining. In 6 surgical specimens
between 1 and 6 additional adenomas were found in the normal
mucosa distant from the tumours. The patients had a mean age of
66 ± 3 years (12 male, 8 female). 
In addition, 14 patients with colorectal cancer and lymph node,
liver and/or peritoneal or lung metastases, 12 patients without
metastases (13 male, 13 female, mean age: 65 ± 2), 3 patients with
polyposis coli (2 male, 1 female, mean age: 51 ± 7 years) and 6
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4 years) were examined by factor VIII and VEGF immunostaining
only. 
The specimens studied were staged according to the TNM clas-
sification of the UICC (5th edition 1997) and the Dukes classifica-
tion as follows: 12 patients with villous adenomas; 4 patients with
polyposis coli, 25 patients with non-metastatic tumours (1 Dukes
A, T1, N0, M0; 24 Dukes B, T2–3, N0, M0) and 21 patients with
metastatic tumours (5 Dukes C, Tx, N1–2, M0, 16 Dukes D Tx, Nx,
M1). The grading was in most cases G2 (41 patients G2, 5 patients
G3). 
All surgical specimens and tissue samples were obtained from
the Department of General and Abdominal Surgery of the
Johannes Gutenberg-University Mainz with the written consent of
the patients in accordance with the local ethical committee’s
approval and the regulations laid down by law. 
Microvascular corrosion casting 
The specimens were transferred immediately after surgery to the
Department of Anatomy. The main supplying arteries were cannu-
lated with olive-tipped cannulas. Blood was washed out by infu-
sion of body-warm buffered physiological saline added with
heparin. Before injection of 80–120 ml Mercox CL-2B (Vilene
Med Co, Tokyo Japan) diluted with 20% methylmethacrylate
monomers (Merck Darmstadt, Germany), up to 100 ml of 2.5%
body temperature glutaraldehyde was perfused as fixative. On
average 3–5 tissue blocks with a diameter of 0.8–1.0 cm were
excised from the tumour centre, the periphery and the invasive
edge and/or polyps. From each specimen at least 2 samples of
normal mucosa were harvested distant from the lesion. 
After additional tissue excision for immunostaining, the surgical
specimens were fixed in 4% formalin and brought to the
Department of Pathology. Extensive preceding experiments,
which were carried out before this study on human surgical speci-
mens, have shown that the casting procedure does not interfere
with the histopathological diagnosis. 
The casting specimens were prepared for scanning electron
microscopy as described in detail earlier (Konerding et al, 1999).
From all specimens between 10 and 25 stereo pairs of peripheral
and central areas were recorded as stereo images using a tilt angle
of 6˚. 
3D morphometry 
Pairs of stereo images were analysed after 3D reconstruction with
an image analysis program (KS 300, Carl Zeiss Vision, Eching,
Germany) to calculate parameters that describe the microvascular
network architecture such as the intervessel and the interbranching
distances as well as the branching angles and diameters. For 
details of the reconstruction and calculation see Malkusch et al
(1995). 
Immunohistology 
Primary polyclonal rabbit anti-human factor VIII (DAKO,
Hamburg), and anti-VEGF (Zymed Laboratories, USA) antibodies
were used. Briefly, the sections were irradiated in a microwave
oven, incubated with goat serum and then incubated with the
primary antibodies. The secondary biotinylated goat anti-rabbit
antibody was connected with either the avidin-biotin-peroxidase
complex (Vectastatin ABC-Kit, Vector Laboratories) or with the
Envision® kit (Dako, Hamburg, Germany). Finally, the AEC
substrate was applied, and the specimens were stained with
haematoxylin. 
The specimens were analysed blindly by 3 different observers.
The extent of the immunostaining for VEGF was estimated by
counting the number of positive cells/10 high power fields 
(diameter 1.235 mm) in a Zeiss axiophot microscope (Zeiss
Oberkochen, Germany). Results were classified according to 5
categories: 0, negative; 1, 1–25% cells positive; 2, 26–50% cells
positive; 3, 51–75% cells positive; 4, 76–100% cells positive. 
In factor VIII staining, in up to 5 different sections per case 1 to
6 hot spots per section were analysed. 5 tumours were excluded
due to a poor factor VIII staining. Within the hot spots the vascular
densities were evaluated based on the criteria of Weidner et al
(1991) by means of an image analysis program (KS 300, Carl
Zeiss Vision, Eching, Germany). 
Statistical analysis 
Statistical analyses and graphic displays were performed using
SigmaStat and SigmaPlot (SPSS, Erkrath, Germany). All groups
were tested for the form of their frequency and distribution before
analysis. The differences in the frequency distribution were tested
for significance using the c2 test, whereas the testing for signif-
icant differences using the mean and standard error of mean
(SEM) of the distribution was performed with the Mann–Whitney
rank sum test and analysis of variance (ANOVA). The sensitivity
was assessed by means of a power calculation which revealed 
d values higher than 80% at the 5% level of confidence. 
RESULTS 
Vascular architecture in normal and pathological
colorectal mucosa 
The mucosal capillary plexus of the large intestine is typically
arranged in a regular, hexagonal honeycomb pattern around the
mucosal glands (Figure 1A, B). The plexus is supplied by arteries
that divide within the submucosa to subepithelial capillaries.
Venous drainage takes place by venules originating immediately
under the mucosal surface and leading to submucosal veins. This
basic pattern is seen in all parts of the large intestine from the
caecum to the rectum. However, there is some heterogeneity in the
number of capillary layers around each crypt in the individual
colonic segments as well as in individual specimens. 
The unique branching pattern of the mucosal plexus is not
retained in tumours. Low-power magnification of the corrosion
casts reveal the characteristic features of tumour vascularity in all
specimens examined such as a low or missing vessel hierarchy,
heterogeneous intratumour vascular densities, and blind-ending
vessels (Figure 1C, D). In general, the vascular density declines
from the tumour periphery to the tumour centre. Especially, in
these areas with lower vascular density numerous vessel compres-
sions and elongated vessel segments are seen. The vessel diame-
ters in general are increased. Changes in diameter within
individual vessel segments suggest altered blood flow characteris-
tics. Comparisons of tumours grown in different colonic segments
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The same was true for differences in tumour sizes. 
The loss of the normal vascular architecture pattern is already
visible in solitary adenomas (Figure 1E, F). The reduction of the
1356 MA Konerding et al 
British Journal of Cancer (2001) 84(10), 1354–1362 © 2001 Cancer Research Campaign
A
C
E F
D
B
c
c
a
a
a
a
v
Figure 1 Scanning electron micrographs of corrosion casts of the colorectal vascularity in normal mucosa (A, B), carcinoma (C, D) and adenoma (E, F).
A, B In the normal mucosa, the capillaries (c) are arranged honeycomb like around the crypts. Ascending arterioles (a) from the submucosa ascending feed
this plexus, which is drained by parallel descending veins (v). The overview in A shows how the mucosal plexus follows the mucosal foldings. C, D Vascular
architecture in adenocacinomas. C: note the markedly expressed heterogeneity in vascular densities and nearly avascular areas in the centre (adenocarcinoma
of descending colon; pT3, pN0, pMx, G2). Vessel compressions, changes in diameter (arrows), and blind ending vessels (l l) are seen in all carcinomas
(sigmoidal adenocarcinoma; pT3, pN3, pM1, G2). E, F Solitary adenoma with high vascular density in the luminal surface (E) and vascular plexuses in the
centre (F), again with loss of vascular hierarchy. Bars in A, C, E = 1 mm, bars in B, D, F = 100 mm Microvasculature of human colon adenomas and carcinomas 1357
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vascular hierarchy in the central parts was so pronounced that in
4 of 10 adenomas the examiners were not able to distinguish
adenomas from carcinomas when double-blinded. In 6 of 10
adenomas nearly all characteristics of the tumour vascular archi-
tecture can be found, however, to varying extents and less
expressed than in the carcinomas. 
Morphometry of the microvascular unit in normal
colorectal mucosa and carcinomas 
Because of the obvious qualitative differences in the peripheral
and central tumour parts we analysed the microvessel architecture
separately in the tumour centre, the luminal surface and periphery. 
The distribution curve of intervessel distances (Figure 2A) as
parameter for vascular density of the control mucosa has an
uniform shape with a peak at 101 mm. It is plotted on a logarithmic
scale because the data most closely approximate to a log normal
distribution. The higher vascular densities in the periphery of the
tumours shift the curve to the left. The curves of the tumour centre
and the luminal tumour surface are flattened and wide based
reflecting the heterogeneity in intervessel distances. All differ-
ences are highly significant (P < 0.0001). Mean values with
maximal and minimal values are summarized in Table 1. 
Figure 2B shows the quantification of the distances between
successive branches. The normal tissue network shows a
branching every 40–80 microns. In the peripheral tumour surface
nearly identical interbranch distances are seen, whereas in the
central tumour surface and tumour centre there are clear differences
in the range and the median values and the patterns of the distribu-
tions. Branching occurs less frequently and much more heteroge-
neous when compared to the tumour periphery and the normal
mucosa (P < 0.001). 
The branching angles of the vessels (Figure 2C) range from
almost zero to almost 180˚ with a median value of about 87˚ in the
normal tissue and 72˚ in the tumours. This is the only parameter
which we have analysed that shows no significant differences
between the individual tumour areas. However, the distribution
curves with smaller angles are significantly different from the
normal mucosa (P < 0.0001). 
When plotting the vessel diameters, distinct patterns emerge for
the tumour areas. In all regions, the tumour vessels have signifi-
cantly wider diameters (P < 0.0001). The largest calibre vessels
are found in the centre, where also the highest dispersion is seen.
Within individual vessel segments, i.e., between 2 successive
branches, the diameters vary in the normal tissue less than 5%,
whereas in the tumour centre and luminal surface very large vari-
abilities of up to 125% deviation from the mean diameter are seen
(P < 0.0001; data not shown). 
These data prove that the tumour microvascular network differs
in many aspects from the normal tissue microvascular architecture
but shows also significant differences within the tumour. We have,
however, not seen significant differences between individual
colorectal tumours or between different tumour localization with
the examined parameters. This gives further evidence for the
existence of a tumour type-specific vascular architecture. 
Table 1
Intervessel distances 
mean ± SEM minimum maximum number 
control 101.5 ± 0.7 41.7 181.2 1127 
tumour periphery 54.3 ± 0.7 3.9 494.6 2486 
Iuminal tumour surface 118.6 ± 2.0 8.5 1181.5 2627 
tumour centre 177.7 ± 3.4 19.3 1756.3 2087 
adenomas 53.99 ± 1.0 11.5 225.23 923 
polyposis 92.47 ± 1.3 3.88 1181.5 210 
Interbranch distances (mm) 
mean ± SEM minimum maximum number 
control 51.2 ± 0.5 2.2 238.5 3001 
tumour periphery 50.2 ± 0.49 5.7 336.3 3517 
Iuminal tumour surface 78.5 ± 1.05 6.6 920.8 3467 
tumour centre 131.9 ± 2.39 9.18 896.1 1855 
Branching angles (˚) 
mean ± SEM minimum maximum number 
control 87,1 ± 0.7 7.4 167.9 1806 
tumour periphery 72.8 ± 0.69 0.57 175.6 2236 
Iuminal tumour surface 71.7 ± 0.68 1.2 171.5 2306 
tumour centre 75.9 ± 1.65 1.7 174.2 1742 
Vessel diameter 
mean ± SEM minimum maximum number 
control 12 ± 0.1 6.4 20.9 4750 
tumour periphery 19.4 ± 0.1 5.6 53.5 4500 
Iuminal tumour surface 18.3 ± 0.1 2.2 84.5 4500 
tumour centre 30.9 ± 0.4 0.9 161.9 47501358 MA Konerding et al 
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Figure 2 Common logarithmic distribution of the intervessel distances (A), interbranch distances (B), branching angles (C), and vessel diameters (D)
quantified in 3D scanning electron micrographs of corrosion casts of 20 colorectal adenocarcinomas and control mucosa. c = control mucosa, tp = tumour
periphery, Its = luminal tumour surface, tc = tumour centre. For means, minimum and maximum values see Table 1 
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Figure 3 Intervessel distances (A), vessel diameters (B), vascular surface volumes (C) and vessel counts (D) in metastastatic (filled dots and columns) vs.
non-metastatic (open dots and columns) colorectal adenocarcinomas. A and B were measured in 3D reconstructed corrosion casts in areas of highest vascular
densities (hot spots), whereas the data shown in C and D derive from anti-factor VIII stained sections. The obvious difference in intervessel distances in hot
spots (A; P < 0.0001) is paralleled by significant differences (P < 0.0001) in the vascular surface areas (C) and vessel counts (D) within hot spots (hs), whereas
in the tumour periphery (tp) and the tumour centre (tc) no significant differences are seen Vascular architecture in metastastatic vs.
non-metastastatic tumours 
Comparisons of primary tumours which have already metastasized
with colorectal tumours without metastases at the time of surgery
revealed no difference in the vascular architecture in the tumour
centre and periphery (data not shown). However, separate
measurements of intervessel distance only in the areas of highest
vascular density, so-called hot spots, showed significant differ-
ences (P < 0.001). Figure 3A shows that the intervessel distances
in metastatic tumours are shorter than in non-metastatic colorectal
adenocarcinomas. The diameters of vessels of metastatic carci-
nomas are slightly smaller than that of non-metastatic primaries
(Figure 3B). 
This finding in corrosion casts was cross-checked in a larger
series in serial sections stained with anti-factor VIII. In total, 46
patients were examined. Figure 3C and D show that indeed no
significant differences can be seen in the vascular densities (vessel
count; 3D) or percentage vascular surface areas (3C) in the tumour
centre or periphery. In contrast, when measuring these parameters
only in the hot spots, a significant result (P < 0.0001) is evident. 
Vascularity of pre-cancerous lesions 
The adenomas shared many architectural features with the carci-
nomas despite the better maintenance of the vascular hierarchy.
Figure 4A shows that the distribution curve of the intervessel
distances has nearly the same shape, median value, minimum and
maximum like that of the tumour peripheral surface. However, the
variability between individual adenomas is by far higher than
between individual carcinomas. 
In the case of the patient with polyposis coli a different vascular
architecture was observed (Figure 4B). The distribution curve of
the intervascular distances showed two distinct peaks. The right
peak was congruent with that of the normal mucosa whereas the
left peak is comparable to that of adenomas and carcinomas.
Obviously, these peaks reflect the progress from normal tissue to
malignant lesion. 
VEGF expression in adenomas and carcinomas 
Figure 5 shows a comparison of VEGF expression in controls (A),
carcinomas (B) and adenomas (C) with virtually no difference
between carcinomas and adenomas. All colon carcinomas
expressed VEGF detected by immunohistochemistry with a strong
cytoplasmic signal. No staining was obtained in normal mucosa
adjacent to the tumour areas as well as at the resection margins. 
VEGF expression did not differ between adenomas and poly-
posis coli patients (P = 0.943). Similar results were obtained
comparing metastatic and non-metastatic adenocarcinomas (P =
0.566). However, adenomas and polyposis coli differed signifi-
cantly from metastatic adenocarcinomas (P = 0.005 for adenomas;
P = 0.003 for polyposis) and non-metastatic carcinomas (P = 0.024
for adenomas; P = 0.012 for polyposis). The results of the semi-
quantitative scoring are summarized in Figure 6. 
DISCUSSION 
The significance of angiogenesis for tumour growth and metastasis
has been stressed in numerous studies of the structure and biolog-
ical properties of the tumour vasculature and blood flow
(Folkman, 1976; Jain, 1988; Folkman and D’Amore, 1996).
Despite the importance of angiogenesis in tumour biology and
antiangiogenic and vascular targeting concepts, literature reviews
show a divergence of opinions on the question of tumour speci-
ficity of the vascular architecture, even though all normal tissues
and organs develop a specific and characteristic vascular architec-
ture fulfilling their specific functional and nutritive requirements
(for review, see Konerding et al (1995)). 
Nearly all studies of the tumour vascular architecture are based
on qualitative, descriptive light microscopic and/or angiographic
2D methods, which enable a morphometric assessment of the
gross network but cannot adequately describe the 3D microvas-
cular architecture. This can best be done with 3D reconstruction of
corrosion casts (Konerding et al, 1995) since the whole terminal
blood stream from the arterial to the venous segment including the
capillary bed can be clearly shown. 
Using this method we have recently demonstrated tumour type-
specific vascular architectures in xenografted murine and human
tumours (Konerding et al, 1999). Furthermore, the vascular archi-
tecture of an experimental tumour does not depend on the size
and/or the rate of growth of the lesion but rather on features char-
acteristic of the tumour cell type. In the first attempt to define the
Microvasculature of human colon adenomas and carcinomas 1359
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Figure 4 Common logarithmic distribution of intervessel distances in
control colorectal mucosa (c), tumour periphery (tp), and in adenomas (A).
Note the striking similarity of the vessel densities in carcinomas and
adenomas. In B, the intervessel distance distribution within the mucosa of
polyposis coli (p. coli) reveals a double peak reflecting high vascular
densities like in adenomas or tumours, whereas the second peak reflects the
normal intervessel distance distribution influence of a single, defined growth factor on the 3D tumour
vascular pattern, we demonstrated that FGF-2 expression and
release induce a faster formation of the microvessel network but
do not change the basic geometry (Konerding et al, 1998). 
In the present study, our first question was whether human
primary colorectal tumours develop a uniform microvascular
architecture. A prerequisite for this study was to exclude any
differences in the normal mucosa of the individual colorectal
segments, since the pre-existing normal vasculature might also
determine the tumour vascular network. In a recent corrosion
casting study of all colorectal segments, no significant inter- and
intra-individual differences of the microvascular architecture were
detected (Fait et al, in press). Thus, it was permissible to pool the
control data. The present study did not show any significant differ-
ences in the microvascular architecture between the individual
tumours, which indicates again a tumour type-specific vascularity.
However, clear differences were seen in the individual tumour
areas, again irrespective of localization and total tumour size.
Interbranch and intervessel distances were significantly shorter in
the periphery including the invasion front than in the tumour
centre. This was also demonstrated in the anti-factor-VIII vessel
counts. 
Vessel counts are increasingly done because of their possible
significance as predictive assay. In colonic carcinomas there is
strong evidence for their predictive value (Weidner et al, 1993;
Takahashi et al, 1997; Wong et al, 1999). At first glance, this
seems to be contrary to our finding of a uniform microvascular
architecture in colorectal carcinomas. In fact there is no contradic-
tion since we assessed our parameters in at least 10 areas 
per tumour region covering approximately 30–35% of the tumour
volume whereas hot spots make up at best 1% of the tumour
volume. When assessing separately the areas of highest vascular
densities in our casts, it also turned out that metastatic tumours
have a significant lower intervessel distance than non-metastatic
tumours. For the parameters interbranch distance, branching angle
and vessel diameter, no significant differences were seen. Also our
anti-factor VIII immunostaining showed no differences in the
vascular surface areas and vessel counts in the tumour centre and
in the peripheral areas. Only the hot spots within the periphery and
the invading edge were significantly different. Therefore we
conclude that the basic microvascular architecture of colorectal
carcinomas is retained despite the increase in vessel density within
the hot spots of metastatic tumours. 
The second question of this paper was the vascularity of
precursor lesions. The concept of an ‘angiogenic switch’ with an
1360 MA Konerding et al 
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Figure 5 Expression of VEGF in normal colonic mucosa (A), in an
adenocarcinoma (B), adenocarcinoma of descending colon, pT3, pN1, pMx;
G2) and an adenoma (C). In B, more than 75% of the cells in the tumour
tissue express a strong signal, which can also be seen in the adenoma 
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Figure 6 Semiquantitative scoring of the VEGF expression in control tissue,
adenomas, polyposis coli, metastatic and non-metastatic colorectal
carcinomas (O, negative; 1, 1–25%; 2, 26–50%; 3, 51–75%; 4, 76–100% of
cells positive). Note the high variability of VEGF expression especially in the
pre-cancerous lesions as compared to the carcinomas avascular, dormant phase of tumour growth followed by the
vascular phase, is widely accepted. Even though numerous details
of the molecular biological basis are still unknown, there is strong
evidence that the induction of vessel growth may occur early in the
adenoma–carcinoma sequence. K-ras mutations, a frequent muta-
tion in colorectal tumours, have been found already in 24% of
human colorectal adenomas (Ajiki et al, 1995). Since mutant ras is
known to up-regulate VEGF (Arbiser et al, 1997) it seems to be
obvious that angiogenesis sets in long before the development of
invasive carcinoma. In numerous adenomas we have seen VEGF
expression comparable to that in carcinomas supporting this
opinion. The difference between adenomas and carcinomas in our
series was significant, whereas Wong et al (1999) and Takahashi 
et al (1998) found no difference. This contradiction may in part be
explained by different methodology. On the other hand it is
possible that VEGF alone is not sufficient for tumorigenicity of
human colorectal carcinoma cells (Okada et al, 1998). Since other
growth factors are also involved in angiogenesis processes
(Carmeliet, 2000) it is likely that besides VEGF other molecules
are needed to effectively promote tumour angiogenesis. 
The up-regulation of VEGF in the adenomas obviously induces
the described changes in vascular architecture which was very
similar to that of the tumour periphery. From that we conclude that
a part of the events that are summarized under ‘tumour angiogen-
esis’ and the ‘angiogenic switch’ may take place already before the
transformation to the carcinoma and is likely to reflect a contin-
uous process. 
A sequence of events is also suggested by the striking similari-
ties of the 3D vascular architecture in a part of the adenomas and
carcinomas. We cannot conclusively answer the question in
general whether the distinct tumour vascular architecture is corre-
lated to the expression of VEGF. However, morphometry of inter-
vascular distances in polyposis coli specimens, which have shown
a high variability in VEGF expression within individual patients,
displays a double-humped distribution curve with a first peak
congruent with that of the normal mucosa and a second one
comparable to that of adenomas and carcinomas in corrosion casts.
Therefore, we conclude that most likely only the amount of new
vessel formation is correlated to the VEGF expression whereas the
overall 3D vascular architecture seems to be determined by the
tumour cells. Comparisons of adenocarcinomas expressing lower
levels of VEGF had virtually the same microvascular network
patterns like that with high VEGF expression levels. This parallels
our recent studies on the impact of FGF-2 on the microvascular
architecture, where we have shown that the overall new vessel
production is positively correlated to the FGF-2 level whereas the
basic geometry of the tumour inherent vascular network is
expressed independent from the FGF-2 level (Konerding et al,
1998). 
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